TECH Bio-Techne Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
15:00
Aug 13
Max Kettner Chief Multi-Asset Strategist, HSBC Bloomberg Markets
Lower rate volatility boosts US growth equities.
A dovish repricing of front-end US rates and lower fixed-income volatility will provide a strong tailwind for US equities, particularly the tech, growth, and momentum complexes, as the US exceptionalism narrative unwinds.
TECH
HIGH
15:22
Aug 12
Keith Lerner Chief Investment Officer, Truist Wealth Bloomberg Markets
AI remains the dominant secular market theme.
AI remains the dominant secular theme driving the market cycle, and despite high volatility and cash flow concerns, the major players will figure out monetization.
TECH
HIGH
17:27
Jul 15
Victoria Fernandez Representative, Crossmark Global Investments Bloomberg Markets
Rotate from overbought tech into financials.
Financials are in an uptrend with many banks hitting three-month highs, while tech appears overbought. This supports rotating out of tech and into financials for the coming months.
TECH
MED
11:59
Jun 25
zerohedge Financial blog / news aggregator
Premarket movers report shows semiconductor stocks surging while hyperscalers decline.
Premarket movers report shows semiconductor stocks surging while hyperscalers decline, along with significant moves in ARS Pharmaceuticals, Bio-Techne, BlackBerry, Dollar Tree, HB Fuller, IBM, Jefferies Financial, Micron Technology, Trip.com ADRs, Qualcomm, and Wendy's.
TECH
11:02
Jun 25
Bloomberg Newswire (@business)
Merck KGaA agrees to acquire Bio-Techne Corporation for 11.3 billion dollars in its largest.
Merck KGaA agrees to acquire Bio-Techne Corporation for 11.3 billion dollars in its largest acquisition in over a decade to bolster its life-science business.
TECH
09:36
Jun 25
FirstSquawk Newswire (@FirstSquawk)
Merck agrees to acquire Bio-Techne for 73 dollars per share in an all-cash deal.
TECH
12:52
Jun 15
Bloomberg Newswire (@business)
Activist investor Ananym Capital Management has built a stake in Bio-Techne and is pushing.
Activist investor Ananym Capital Management has built a stake in Bio-Techne and is pushing the board to conduct a strategic review that would include a potential sale.
TECH
13:00
May 06
Guidance is cautious, projecting flat to low single-digit growth in the near term due to lingering biotech softness, but management points to a stronger FY2027 as funding translates to spending and company-specific headwinds roll off.
TECH
HIGH
01:57
Apr 17
Yung-Yu Ma Chief Investment Strategist, PNC Asset Management CNBC
Tech to lead market gains.
Tech sector will reassert leadership as it facilitates productivity gains, driven by AI, with semiconductors and other areas leading.
TECH
HIGH
11:23
Apr 15
Monica DiCenso Senior Macro Strategist, Wells Fargo CNBC
Reduce exposure to overowned tech stocks.
After the market rally, it is a good time to reposition and move out of tech because most investors are overweight, making tech likely overowned and prone to underperformance.
TECH
MED
23:42
Apr 01
Bloomberg Markets Bloomberg Markets
The market summary states the Nasdaq 100 was higher by about 1.2% as people were "taking a bid back into tech companies" on optimism about a potential end to the Iran conflict. A de-escalation in Iran reduces geopolitical risk premiums, favoring growth-oriented sectors like technology. The sector was a highlighted leader in the day's rally. The explicit mention of capital flowing back into tech as a direct response to positive geopolitical developments indicates a clear, positive short-term catalyst for the sector. The Iran conflict does not de-escalate as expected, or other macro headwinds re-emerge.
TECH
17:48
Mar 27
Michael Kantrowitz Chief Investment Strategist, Piper Sandler Bloomberg Markets
The Nasdaq 100 is in a correction, down over 10% from its peak. Tech is getting hit from macro pressures (higher yields, oil) and sector-specific AI disruption fears. Higher oil and rates compound to create a multiple compression environment for growth stocks. The sector is also facing idiosyncratic disruption scares (e.g., AI in cybersecurity, memory chips). In the near term, tech is not a safe haven and is exposed to both macro and micro headwinds. A rapid de-escalation in Iran could bring down oil and yields, relieving the macro pressure. Strong earnings revisions could also provide support.
TECH
14:00
Feb 04
Management is confident in a gradual recovery, supported by easing headwinds and improvement in end markets.
TECH
HIGH
14:00
Nov 05
Management guidance is mixed: Q2 organic growth is expected to be flat (consistent with Q1), with a return to positive organic growth expected only in the second half of the year as they lap prior-year headwinds.
TECH
HIGH

About TECH Analyst Coverage

Buzzberg tracks TECH (Bio-Techne) across 6 sources. 4 bullish vs 0 bearish calls from 10 analysts. Sentiment: predominantly bullish (29%). 14 total trade ideas tracked. Latest voices: Max Kettner, Keith Lerner, Victoria Fernandez.